MS Morgan Stanley

Replacement Rate for U.S. Law-Governed U.S. Dollar LIBOR-Linked Preferred Stock (and Related Depositary Shares), Debt Securities and Certificates of Deposit

Morgan Stanley (NYSE: MS) announced today that, except for the instruments identified below, the U.S. law-governed U.S. dollar LIBOR-linked preferred stock (and related depositary shares) and debt securities issued by Morgan Stanley and Morgan Stanley Finance LLC, and certificates of deposit issued by Morgan Stanley Bank, N.A., will transition from using U.S. dollar LIBOR as a benchmark to the CME Term SOFR Reference Rate published for the tenor corresponding to the relevant U.S. dollar LIBOR rate plus a tenor spread adjustment (the “Replacement Rate”) (i) by operation of law, pursuant to the Adjustable Interest Rate (LIBOR) Act, or (ii) pursuant to the terms of such instruments. The replacement of U.S. dollar LIBOR with the Replacement Rate will be effective for determinations that are made after June 30, 2023 (the “Cessation Date”), when the relevant U.S. dollar LIBOR settings are expected to either cease publication or no longer be representative but will not affect any determinations made on or prior to the Cessation Date.

The tenor spread adjustment for each applicable U.S. dollar LIBOR tenor is listed below:

Tenor

   

Tenor Spread

Adjustment

1 Month

   

0.11448%

3 Months

   

0.26161%

6 Months

   

0.42826%

The following chart identifies the U.S. law-governed U.S. dollar LIBOR-linked preferred stock (and related depositary shares) and debt securities issued by Morgan Stanley that will not transition to the Replacement Rate by operation of law or otherwise. After the Cessation Date, dividends or interest on these instruments will continue to accrue at the specified fixed rate.

Morgan Stanley-Issued Preferred Stock (and Related Depositary Shares)

CUSIP

 

Description

61762V200

 

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E (and related depositary shares) (7.125%)

61763E207

 

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F (and related depositary shares) (6.875%)

61761J406

 

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I (and related depositary shares) (6.375%)

61762V606

 

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K (and related depositary shares) (5.850%)

61762VAA9

 

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M (5.875%)

Morgan Stanley-Issued Debt Securities

CUSIP

 

Description

61744YAK4

 

Global Medium-Term Notes, Series I, Fixed/Floating Rate Senior Notes Due 2028 (3.591%)

61744YAL2

 

Global Medium-Term Notes, Series I, Fixed/Floating Rate Senior Notes Due 2038 (3.971%)

Additional information regarding these instruments is available by accessing The Depository Trust & Clearing Corporation’s (DTCC) LIBOR Benchmark Replacement Index solution through DTCC’s Legal Notice System (LENS). This announcement does not apply to any U.S. dollar LIBOR-linked instruments issued by Morgan Stanley or any of its affiliates that are not governed by U.S. law.

Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit .

EN
28/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Morgan Stanley

Morgan Stanley: 1 director

A director at Morgan Stanley sold/sold after exercising options 32,968 shares at 182.611USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...

Morgan Stanley: Robust Q4 results reflect wealth and investment bankin...

Credit positive Q4 results again shows robust performances across business segments.

Global Investment Banks – US: Large banks' Q4 debt underwriting, equit...

Strong debt issuance volume will likely benefit investment banking fees; secondary market volumes were robust, supporting trading revenue, especially in equities.

Morgan Stanley: Update to credit analysis

Our credit view of this issuer reflects its strong capital and liquidity, against its confidence-sensitive customers and a high reliance on wholesale funding.

Morgan Stanley: Q3 reflects strong equity trading, an investment banki...

Credit positive Q3 results shows robust performances across business segments, including an exceptional quarter for the capital markets business, delivering a 45% jump in net income.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch